The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis. - Kivitz A; Wang L; Alevizos I; Gunsior M; Falloon J; Illei G; St Clair EW (RMD open, 2023)